TO evaluate the use of calcium supplementation in the treatment of premenstrual syndrome.
DATA SOURCES:
Clinical literature accessed through MEDLINE (from January 1967 to September 1999). Key search terms included calcium, PMS, and premenstrual.
DATA SYNTHESIS:
Up to 50% of women experience some form of premenstrual syndrome. An evaluation of studies focusing on calcium in the management of premenstrual symptoms was conducted.
CONCLUSIONS:
Calcium supplementation of 1200–1600 mg/d, unless contraindicated, should be considered a sound treatment option in women who experience premenstrual syndrome. The supplemental dose of calcium can be adjusted downward in the few patients who routinely consume large quantities of calcium in their diet.
FrankhauserM. Premenstrual syndrome. In: DiPiroJTTalbertRLYeeGCMatzkeGRPoseyLM, eds. Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford, CT: Appleton and Lange, 1997: 1621–33.
2.
Thys-JacobsSAlvirMJ. Calcium-regulating hormones across the menstrual cycle: Evidence of a secondary hyperparathyroidism in women with PMS. J Clin Endocrinol Metab1995;80: 2227–32.
3.
Thys-JacobsSCeccarelliSBiermanAWeismanHCohenMAAlvirJ. Calcium supplementation in premenstrual syndrome: A randomized crossover trial. J Gen Intern Med1989;4: 183–9.
4.
MuseKNCetelNSFuttermanLAYenSSC. The premenstrual syndrome: Effect of medical ovariectomy. N Engl J Med1984;311: 1345–9.
5.
AlvirMJThys-JacobsS. Premenstrual and menstrual symptom clusters and response to calcium treatment. Psychopharmacol Bull1991;27: 145–8.
6.
PenlandJGJohnsonPE. Dietary calcium and manganese effects on menstrual cycle symptoms. Am J Obstet Gynecol1993;168: 1417–23.
7.
Thys-JacobsS. Vitamin D and calcium in menstrual migraine. Headache1994;34: 544–6.
8.
Thys-JacobsSAlvirJMFratarcangeloP. Comparative analysis of three PMS assessment instruments — The identification of premenstrual syndrome with core symptoms. Psychopharmacol Bull1995;31: 389–96.
9.
Thys-JacobsSStarkeyPBernsteinDTianJ. Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol1998;179: 444–52.
10.
O'ConnellMBauwensS. Osteoporosis and osteomalacia. In: DiPiroJTTalbertRLYeeGCMatzkeGRPoseyLM, eds. Pharmacotherapy: a pathophysiologic approach. 3rd ed. Stamford, CT: Appleton and Lange, 1997: 1689–716.
